bf/NASDAQ:CSTL_icon.jpeg

COM:CASTLEBIOSCIENCES

Castle Biosciences

  • Stock

USD

Last Close

28.88

22/11 21:00

Market Cap

482.57M

Beta: -

Volume Today

314.82K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
1.40
-
1.02
27.39%
0.43
57.41%
0.14
67.08%
0.20
42.63%
0.31
50.62%
0.46
50.15%
cash conversion cycle
63.23
-
154.49
144.31%
71.73
53.57%
78.82
9.89%
54.93
30.30%
53.96
1.77%
48.33
10.45%
cash per share
0.12
-
0.42
239.44%
11.52
2,638.40%
21.65
88.03%
13.11
39.44%
9.93
24.30%
9.07
8.63%
company equity multiplier
-0.69
-
-2.23
223.36%
1.41
163.23%
1.06
24.88%
1.12
6.30%
1.12
0.25%
1.22
8.97%
days of inventory outstanding
22.59
-
60.79
169.15%
61.77
1.60%
83.55
35.27%
46.62
44.20%
45.38
2.66%
52.18
14.98%
days of payables outstanding
82.82
-
99.97
20.72%
93.12
6.85%
79.07
15.09%
58.73
25.72%
53.95
8.15%
67.46
25.05%
days of sales outstanding
123.46
-
193.66
56.86%
103.09
46.77%
74.34
27.89%
67.05
9.81%
62.53
6.74%
63.61
1.73%
dividend yield
ebit per revenue
-0.79
-
-0.17
78.76%
0.09
153.91%
-0.10
215.06%
-0.43
307.94%
-0.67
56.13%
-0.31
53.50%
ebt per ebit
1.13
-
1.66
46.19%
1.14
31.45%
1.56
37.20%
1.00
35.97%
0.76
24.27%
0.84
11.62%
effective tax rate
-0.00
-
-0.00
71.91%
0.01
1,094.50%
-0.01
161.18%
0.22
2,746.35%
0.03
88.24%
-0.00
106.87%
enterprise value multiple
-21.81
-
-65.91
202.27%
43.69
166.29%
-151.17
445.98%
-20.66
86.34%
-6.57
68.18%
-8.89
35.30%
fixed asset turnover
9.36
-
14.90
59.24%
25.18
68.95%
8.82
64.96%
5.57
36.83%
5.17
7.18%
5.82
12.60%
free cash flow per share
-1.30
-
-1.18
9.27%
0.71
159.99%
0.27
61.84%
-0.89
430.81%
-1.81
103.07%
-0.51
71.72%
gross profit margin
0.64
-
0.77
19.53%
0.86
11.92%
0.85
1.59%
0.83
1.61%
0.77
7.86%
0.75
2.50%
interest coverage
-6.61
-
-1.69
74.47%
1.03
161.05%
-2.48
341.19%
-40.08K
1,613,597.43%
-5.36K
86.62%
-6.18K
15.27%
inventory turnover
16.16
-
6.00
62.85%
5.91
1.57%
4.37
26.08%
7.83
79.21%
8.04
2.73%
6.99
13.02%
long term debt to capitalization
5.28
-
1.70
67.87%
0.18
89.12%
0.02
-
0.03
70.38%
0.04
24.69%
net income per ebt
1.00
-
1.00
0.06%
0.99
1.48%
1.01
2.20%
0.78
22.43%
0.97
24.59%
1.00
2.81%
net profit margin
-0.90
-
-0.28
68.93%
0.10
136.41%
-0.16
261.34%
-0.33
102.61%
-0.49
47.30%
-0.26
46.63%
operating cash flow per share
-1.25
-
-1.15
7.68%
0.82
170.79%
0.52
36.23%
-0.76
244.90%
-1.60
111.71%
-0.01
99.68%
operating cycle
146.05
-
254.46
74.23%
164.85
35.21%
157.89
4.22%
113.67
28.01%
107.91
5.06%
115.79
7.30%
operating profit margin
-0.79
-
-0.17
78.76%
0.09
153.91%
-0.10
215.06%
-0.43
307.94%
-0.67
56.13%
-0.31
53.50%
payables turnover
4.41
-
3.65
17.16%
3.92
7.35%
4.62
17.78%
6.21
34.62%
6.77
8.87%
5.41
20.03%
pretax profit margin
-0.90
-
-0.28
68.95%
0.10
136.96%
-0.16
257.87%
-0.43
161.21%
-0.50
18.23%
-0.26
48.09%
price fair value
-14.67
-
-22.64
54.28%
3.47
115.31%
3.06
11.79%
2.62
14.41%
1.54
41.29%
1.48
3.79%
receivables turnover
2.96
-
1.88
36.25%
3.54
87.87%
4.91
38.68%
5.44
10.87%
5.84
7.22%
5.74
1.70%
return on assets
-1.26
-
-0.28
77.44%
0.04
115.51%
-0.02
153.12%
-0.07
188.99%
-0.15
121.86%
-0.12
19.87%
return on capital employed
-2.37
-
-0.24
89.67%
0.05
118.41%
-0.02
134.69%
-0.09
485.72%
-0.22
142.05%
-0.16
28.70%
return on equity
0.87
-
0.63
27.05%
0.06
90.19%
-0.02
139.90%
-0.08
207.20%
-0.17
121.32%
-0.15
12.68%
total debt to capitalization
4.29
-
1.70
60.47%
0.23
86.58%
0.02
-
0.03
67.69%
0.04
16.87%

All numbers in USD (except ratios and percentages)